/Companies

Exonics Therapeutics

Watertown, US · Founded 2016 · 3 known investors

Find your way into Exonics Therapeutics

Sign up to find every way you can get introduced to Exonics Therapeutics

  • Your email: who you already know at Exonics Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Exonics Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Founders & leadership

JR
John RippleExecutive
JGJesper Gromada
Jesper GromadaChief Scientific Officer2018–2019Investor at Third Rock Ventures
HJ
H. James MageeNamed on SEC filing
RP
Roger PerlmutterNamed on SEC filing

Board

JK
JeenJoo KangBoard directorVenture Partner at The Column Group
DGDavid Goeddel
David GoeddelBoard directorManaging Partner at The Column Group

Investors · 3

Reported raises · per SEC filings

Form D private placements

$22M disclosed across 1 round · 2017

▶$22MraisedNov 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jesper GromadaExecutive Officer
  • H. James MageeExecutive Officer
  • JeenJoo KangDirector
  • David GoeddelDirector
  • Roger PerlmutterDirector
  • John RippleExecutive Officer, Director
Offering amount
$42M
Amount sold
$22M
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Exonics Therapeutics's investors?
Exonics Therapeutics's investors include Artis Ventures, Ridgeback Capital, The Column Group.
How much funding has Exonics Therapeutics raised?
Exonics Therapeutics has disclosed $22M raised across 1 round.
Where is Exonics Therapeutics headquartered?
Exonics Therapeutics is headquartered in Watertown, US.